Phase II failures: 2008–2010
Year: 2011
Type: other
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd3439
Author: John Arrowsmith
Institution: Thomson Reuters (United Kingdom)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2065540447
